PAPPAS CAPITAL
Pappas Capital invests exclusively in the life science sector – biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures – across the United States and Canada. They operate three lines of business: Pappas Ventures, their flagship venture arm; Specialized Fund Management, where we create and manage custom-tailored investment vehicles; and Translational Medicine, where we partner with research universities to accelerate the development of their scientific discoveries and inventions.
PAPPAS CAPITAL
Industry:
Biotechnology Delivery Medical Device Pharmaceutical
Founded:
1994-01-01
Status:
Active
Contact:
919-998-3300
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins Global Site Tag
Current Advisors List
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-25 | Aktis Oncology | Pappas Capital investment in Series A - Aktis Oncology | 84 M USD |
| 2022-06-02 | Yueer Gene | Pappas Capital investment in Series B - Yueer Gene | 50 M USD |
| 2022-06-02 | NuProbe | Pappas Capital investment in Series B - NuProbe | 50 M USD |
| 2022-04-14 | Us2.ai | Pappas Capital investment in Series A - Us2.ai | 15 M USD |
| 2022-02-23 | Plexium | Pappas Capital investment in Series B - Plexium | 102 M USD |
| 2022-01-05 | AvengeBio | Pappas Capital investment in Series A - AvengeBio | 45 M USD |
| 2021-09-29 | BioAtla | Pappas Capital investment in Post-IPO Equity - BioAtla | 75 M USD |
| 2020-12-09 | Reneo Pharmaceuticals | Pappas Capital investment in Series B - Reneo Pharmaceuticals | 95 M USD |
| 2020-07-31 | Cyclerion Therapeutics | Pappas Capital investment in Post-IPO Equity - Cyclerion Therapeutics | 24 M USD |
| 2020-07-15 | BioAtla | Pappas Capital investment in Series D - BioAtla | 72.5 M USD |
More informations about "Pappas Capital"
Team - Pappas Capital
Glenda's broad strong organization skills help keep Pappas Capital running smoothly. Drew Cutshaw, MD. Drew Cutshaw, MD. Principal and Medical Officer. ... Richard brings a wealth of experience and insight to Pappas Capital gained …See details»
Pappas Capital - Crunchbase Investor Profile & Investments
Pappas Capital invests exclusively in the life science sector – biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures – across the United States and Canada. …See details»
About Pappas Capital
Pappas Capital is a global venture capital and commercial development firm investing in next-generation life science, agriculture, and technology companies. We operate three lines of business: Pappas Ventures, our flagship life science …See details»
Pappas Capital - The Org
Pappas Capital is laser focused on the life science sector. For 26 years we have been investing in and building innovative companies that are developing the next generation of life science …See details»
Pappas Capital - Private Equity Investments & Executives
See Pappas Capital's 78 investments, 18 executives, and complete investor profile. Founded in 1994, Pappas Capital operates three lines of business: Pappas Ventures, Specialized Fund …See details»
Pappas Capital Profile - Transacted
Pappas Capital is an investment firm specializing in life science sectors across the U.S. and Canada, including biotech, biopharmaceuticals, and medical devices, with three arms of …See details»
Pappas Capital - Investments, Portfolio & Company Exits
Pappas Capital 's most notable exits include 4D Molecular Therapeutics, ... Which industries has this organization had the most exits in? Show . 4D Molecular Therapeutics 4D Molecular …See details»
Pappas Capital | Private Equity List
Pappas Capital invests exclusively in the life science sector – biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures – across the United States and Canada. …See details»
Pappas Capital investment portfolio - PitchBook
Pappas Capital General Information Company Description. Founded in 1994, Pappas Capital is a venture capital investment firm based in Durham, North Carolina. The firm seeks to invest in …See details»
Pappas Ventures - Pappas Capital
Pappas Ventures is our firm’s flagship business. For 30 years, we have invested in opportunities where we see the potential to generate superior risk-adjusted returns by focusing on novel life …See details»
Arthur Pappas Profile: Contact Information & Network - PitchBook
He founded Pappas Capital in 1994 and over the past two decades, the firm has managed $450 million in capital and invested in more than 70 life science companies through its flagship …See details»
Pappas Capital - Funding, Financials, Valuation & Investors
Pappas Capital has raised a total of $85.8M in a single venture fund, A. M. Pappas Life Science Ventures V. This fund was announced on Jan 15, 2019 and raised a total of . obfuscated. …See details»
Art Pappas - Managing Partner at Pappas Capital - The Org
Art founded Pappas Capital in 1994, and over the past twenty-six years the firm has managed more than $540 million in capital and invested in more than 85 life science companies through …See details»
Investment Executives - Pappas Capital
Drew joined Pappas Capital in January 2020 as a Venture Fellow where he participated actively in investment opportunity evaluation, due diligence and deal flow management. ... and on the …See details»
Pappas Capital Information - RocketReach
The NAICS codes for Pappas Capital are [52311, 523, 52, 523110, 5231]. What is the SIC code for Pappas Capital? The SIC codes for Pappas Capital are [679, 6799, 67]. Top Pappas …See details»
Pappas Capital - Contacts, Employees, Board Members
Pappas Capital has 8 current employee profiles, including Senior Associate, Operations Lisa Dreyer. Pappas Capital has 2 board members and advisors, including Lee Babiss. Contacts. …See details»
Massacre in Haiti’s Capital Leaves Nearly 200 Dead, U.N. Says
11 hours ago That assessment was backed by another rights organization and a Cité Soleil resident. At least 184 people were killed, Volker Turk, the U.N. High Commissioner for Human …See details»
Art Pappas - Pappas Capital
Art is an experienced pharmaceutical and biotechnology industry executive, entrepreneur and venture capital investor. He founded Pappas Capital in 1994, and over the past thirty years the …See details»
Tom Mathers - Pappas Capital
Prior to Pappas Capital and Allievex, Tom was the President and CEO of CoLucid Pharmaceuticals, Inc. (NASDAQ: CLCD), a Pappas Ventures III founded company, which …See details»